• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中炎性细胞因子网络的变化

Changes in inflammatory cytokine networks in myasthenia gravis.

作者信息

Uzawa Akiyuki, Kanai Tetsuya, Kawaguchi Naoki, Oda Fumiko, Himuro Keiichi, Kuwabara Satoshi

机构信息

Department of Neurology, Graduate School of Medicine, Chiba University, Japan.

Department of Neurology, Neurology Chiba Clinic, Japan.

出版信息

Sci Rep. 2016 May 13;6:25886. doi: 10.1038/srep25886.

DOI:10.1038/srep25886
PMID:27172995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865732/
Abstract

Myasthenia gravis (MG) is an autoimmunological inflammatory disorder of the neuromuscular junction. Inflammation could be a key player for understanding the pathogenesis of MG. We measured the serum levels of 24 inflammatory cytokines in 43 patients with anti-acetylcholine receptor antibody-positive MG and 25 healthy controls. In patients with MG, serum levels of a proliferation-inducing ligand (APRIL), IL-19, IL-20, IL-28A and IL-35 were significantly increased as compared with controls (p < 0.05). Among them, IL-20, IL-28A and IL-35 were significantly decreased after treatment (p < 0.05). In clinical subtype analyses, APRIL and IL-20 were increased in patients with late-onset MG and IL-28A levels were increased in patients with thymoma-associated MG compared with healthy controls (p < 0.01). The results of the present study demonstrate both anti-inflammatory and inflammatory cytokines are upregulated in MG, reflecting the importance of cytokine-mediated inflammation and its regulation in MG pathophysiology.

摘要

重症肌无力(MG)是一种神经肌肉接头处的自身免疫性炎症性疾病。炎症可能是理解MG发病机制的关键因素。我们检测了43例抗乙酰胆碱受体抗体阳性的MG患者和25名健康对照者血清中24种炎性细胞因子的水平。与对照组相比,MG患者血清中增殖诱导配体(APRIL)、IL-19、IL-20、IL-28A和IL-35的水平显著升高(p<0.05)。其中,治疗后IL-20、IL-28A和IL-35显著降低(p<0.05)。在临床亚型分析中,与健康对照相比,迟发性MG患者的APRIL和IL-20升高,胸腺瘤相关MG患者的IL-28A水平升高(p<0.01)。本研究结果表明,抗炎和炎性细胞因子在MG中均上调,反映了细胞因子介导的炎症及其调节在MG病理生理学中的重要性。

相似文献

1
Changes in inflammatory cytokine networks in myasthenia gravis.重症肌无力中炎性细胞因子网络的变化
Sci Rep. 2016 May 13;6:25886. doi: 10.1038/srep25886.
2
Serum cytokine and chemokine profiles in patients with myasthenia gravis.重症肌无力患者的血清细胞因子和趋化因子谱。
Clin Exp Immunol. 2014 May;176(2):232-7. doi: 10.1111/cei.12272.
3
An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.儿童期起病的眼肌型重症肌无力患者循环中B细胞活化因子增加。
Pediatr Neurol. 2015 Apr;52(4):404-9. doi: 10.1016/j.pediatrneurol.2014.12.006. Epub 2014 Dec 31.
4
Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.抗乙酰胆碱受体抗体阳性重症肌无力患者体内抵抗素水平显著升高。
J Neuroimmunol. 2015 Jun 15;283:7-10. doi: 10.1016/j.jneuroim.2015.04.004. Epub 2015 Apr 9.
5
Increased serum peroxiredoxin 5 levels in myasthenia gravis.重症肌无力患者血清过氧化物还原酶5水平升高。
J Neuroimmunol. 2015 Oct 15;287:16-8. doi: 10.1016/j.jneuroim.2015.07.013. Epub 2015 Jul 29.
6
High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.高白细胞介素-10产生与青少年重症肌无力患者抗乙酰胆碱受体抗体产生及治疗反应相关。
Int J Neurosci. 2007 Nov;117(11):1505-12. doi: 10.1080/00207450601125840.
7
Expression of interleukin-22 in myasthenia gravis.白细胞介素-22 在重症肌无力中的表达。
Scand J Immunol. 2013 Jul;78(1):98-107. doi: 10.1111/sji.12057.
8
Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.一个家族中的三例重症肌无力,临床表现和血清抗体存在差异。
Neuromuscul Disord. 2012 Mar;22(3):286-8. doi: 10.1016/j.nmd.2011.10.004. Epub 2011 Nov 13.
9
Analysis of Serum Cytokine Profiles in Childhood-Onset Ocular Myasthenia Gravis.儿童期起病的眼肌型重症肌无力患者血清细胞因子谱分析
Pediatr Neurol. 2017 Apr;69:e3-e4. doi: 10.1016/j.pediatrneurol.2017.01.015. Epub 2017 Jan 25.
10
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.肌肉特异性激酶重症肌无力 IgG4 自身抗体导致小鼠严重的神经肌肉接头功能障碍。
Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6.

引用本文的文献

1
Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis.循环炎症蛋白作为重症肌无力的致病介质和潜在治疗靶点
Neurol Sci. 2025 Jun 26. doi: 10.1007/s10072-025-08328-y.
2
Povetacicept (ALPN-303; TACI vTD-Fc), an enhanced, potent dual inhibitor of BAFF and APRIL, ameliorates experimental autoimmune myasthenia gravis in C57BL/6N mice.泊维他西普(ALPN - 303;TACI vTD - Fc),一种增强的、强效的BAFF和APRIL双重抑制剂,可改善C57BL/6N小鼠的实验性自身免疫性重症肌无力。
Front Immunol. 2025 Jun 6;16:1533093. doi: 10.3389/fimmu.2025.1533093. eCollection 2025.
3
Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction.

本文引用的文献

1
Interleukin 19 reduces inflammation in chemically induced experimental colitis.白细胞介素19可减轻化学诱导的实验性结肠炎中的炎症。
Int Immunopharmacol. 2015 Dec;29(2):468-475. doi: 10.1016/j.intimp.2015.10.011. Epub 2015 Oct 23.
2
Increased serum peroxiredoxin 5 levels in myasthenia gravis.重症肌无力患者血清过氧化物还原酶5水平升高。
J Neuroimmunol. 2015 Oct 15;287:16-8. doi: 10.1016/j.jneuroim.2015.07.013. Epub 2015 Jul 29.
3
Myasthenia gravis: subgroup classification and therapeutic strategies.重症肌无力:亚组分类与治疗策略。
突破屏障:促炎细胞因子在血脑屏障功能障碍中的作用
Int J Mol Sci. 2025 Apr 9;26(8):3532. doi: 10.3390/ijms26083532.
4
Serum Inflammatory Factors Levels and Risk of Myasthenia Gravis: A Bidirectional Mendelian Randomization Study.血清炎症因子水平与重症肌无力风险:一项双向孟德尔随机化研究
Mol Neurobiol. 2025 Jun;62(6):7738-7746. doi: 10.1007/s12035-025-04744-5. Epub 2025 Feb 11.
5
The Latest Progress in the Application of Telitacicept in Autoimmune Diseases.泰它西普在自身免疫性疾病中的应用最新进展
Drug Des Devel Ther. 2024 Dec 7;18:5811-5825. doi: 10.2147/DDDT.S493923. eCollection 2024.
6
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.血清蛋白生物标志物谱可区分乙酰胆碱受体抗体血清阳性重症肌无力患者与健康对照。
iScience. 2024 Jul 23;27(8):110564. doi: 10.1016/j.isci.2024.110564. eCollection 2024 Aug 16.
7
Frequency and severity of autonomic dysfunction assessed by objective hemodynamic responses and patient-reported symptoms in individuals with myasthenia gravis.通过客观血流动力学反应和重症肌无力患者报告的症状评估自主神经功能障碍的频率和严重程度。
Front Neurosci. 2024 Jul 19;18:1415615. doi: 10.3389/fnins.2024.1415615. eCollection 2024.
8
Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study.泰利西普治疗难治性全身型重症肌无力的有效性和安全性:一项回顾性研究
Ther Adv Neurol Disord. 2024 May 14;17:17562864241251476. doi: 10.1177/17562864241251476. eCollection 2024.
9
Stereotypic T cell receptor clonotypes in the thymus and peripheral blood of Myasthenia gravis patients.重症肌无力患者胸腺和外周血中的定型性T细胞受体克隆型
Heliyon. 2024 Feb 19;10(4):e26663. doi: 10.1016/j.heliyon.2024.e26663. eCollection 2024 Feb 29.
10
Mendelian randomization analyses of known and suspected risk factors and biomarkers for myasthenia gravis overall and by subtypes.孟德尔随机化分析总体及各亚型重症肌无力的已知和可疑风险因素及生物标志物。
BMC Neurol. 2024 Jan 18;24(1):33. doi: 10.1186/s12883-024-03529-y.
Lancet Neurol. 2015 Oct;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3.
4
Interleukin-19 acts as a negative autocrine regulator of activated microglia.白细胞介素-19作为活化小胶质细胞的负性自分泌调节因子发挥作用。
PLoS One. 2015 Mar 20;10(3):e0118640. doi: 10.1371/journal.pone.0118640. eCollection 2015.
5
B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis.在重症肌无力中,B细胞产生的白细胞介素-10、白细胞介素-6和肿瘤坏死因子-α较少。
Autoimmunity. 2015 Jun;48(4):201-7. doi: 10.3109/08916934.2014.992517. Epub 2014 Dec 18.
6
The IL-20 subfamily of cytokines--from host defence to tissue homeostasis.细胞因子的 IL-20 亚家族——从宿主防御到组织稳态。
Nat Rev Immunol. 2014 Dec;14(12):783-95. doi: 10.1038/nri3766.
7
Serum high mobility group box 1 is upregulated in myasthenia gravis.血清高迁移率族蛋白 1 在重症肌无力中上调。
J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):695-7. doi: 10.1136/jnnp-2014-309232. Epub 2014 Oct 24.
8
Serum cytokine and chemokine profiles in patients with myasthenia gravis.重症肌无力患者的血清细胞因子和趋化因子谱。
Clin Exp Immunol. 2014 May;176(2):232-7. doi: 10.1111/cei.12272.
9
The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.BAFF/APRIL 系统:超越 B 细胞生物学和自身免疫的新兴功能。
Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Epub 2013 May 15.
10
Expression of interleukin-22 in myasthenia gravis.白细胞介素-22 在重症肌无力中的表达。
Scand J Immunol. 2013 Jul;78(1):98-107. doi: 10.1111/sji.12057.